HMG-1 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemHMG-1 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-37982
Quantity10 µM
Gene Namehigh mobility group box 1
Specieshuman
TypesiRNA/dsRNA
NCBI Full Gene Namehigh mobility group box 1
NCBI Gene AliasesHMG-1, HMG1, HMG3, SBP-1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Gut microbiota and HMGB1/NLRP3/GSDMD inflammasome-dependent pyroptosis: mechanisms by physcion ameliorates alcoholic liver fibrosisFrontiers in PharmacologyMarch 27, 2025Ting Bai, Hao-Lin Guo, Fei Wang, Yan-Yu Kang, Hao-Tian Zhang, Lu Dong, Yong YangUnited States). F4/80 (#sc-377009), Caspase-1 (#sc-392736), control siRNA (#sc-37007), HMGB1-siRNA (#sc-37982) were purchased from Santa Cruz Biotechnology, Inc., (CA, United States). PrimeScript™ II 1st Strand

(2) The telomeric protein TERF2/TRF2 impairs HMGB1-driven autophagyAutophagyMay 1, 2023Iachettini S, Ciccarone F, Maresca C, D' Angelo C, Petti E, Di Vito S, Ciriolo MR, Zizza P, Biroccio A.

(3) Endothelial specific deletion of HMGB1 increases blood pressure and retards ischemia recovery through eNOS and ROS pathway in miceRedox biologyMay 1, 2021Zhou Q, Tu T, Tai S, Tang L, Yang H, Zhu Z.

(4) miR-142-3p reduces the viability of human cervical cancer cells by negatively regulating the cytoplasmic localization of HMGB1Experimental and therapeutic medicineMarch 1, 2021Dong H, Song J.

(5) Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axisMolecular immunologyFebruary 1, 2021Wang X, Gao S, Song L, Liu M, Sun Z, Liu J.

(6) HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancerAmerican journal of cancer researchJanuary 1, 2021Jung AR, Kim GE, Kim MY, Ha US, Hong SH, Lee JY, Kim SW, Park YH.

(7) High mobility group box 1 induces bone pain associated with bone invasion in a mouse model of advanced head and neck cancerOncology reportsDecember 1, 2020Nakamura T, Okui T, Hasegawa K, Ryumon S, Ibaragi S, Ono K, Kunisada Y, Obata K, Masui M, Shimo T, et al.

(8) HMGB1 mediates lipopolysaccharide-induced inflammation via interacting with GPX4 in colon cancer cellsCancer cell internationalJanuary 1, 2020Yang Y, Yang L, Jiang S, Yang T, Lan J, Lei Y, Tan H, Pan K.

(9) High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine PathwayMedical science monitor : international medical journal of experimental and clinical researchDecember 9, 2018Cheng P, Ma Y, Gao Z, Duan L.

(10) HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsyMolecular medicine reportsApril 1, 2018Shi Y, Zhang L, Teng J, Miao W.

(11) Indinavir Plus Methylprednisolone Ameliorates Experimental Acute Lung Injury In Vitro and In VivoShock (Augusta, Ga.)February 1, 2018Ji Y, Zhang G, Zhu H, Li D, Jiang W.

(12) MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagyOncotargetDecember 8, 2017Xiong J, Wang D, Wei A, Ke N, Wang Y, Tang J, He S, Hu W, Liu X.

(13) High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progressionCancer scienceAugust 1, 2017Chung HW, Lim JB.

(14) Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interactionHepatology (Baltimore, Md.)July 1, 2017Tohme S, Yazdani HO, Liu Y, Loughran P, van der Windt DJ, Huang H, Simmons RL, Shiva S, Tai S, Tsung A.

(15) Novel involvement of miR-522-3p in high-mobility group box 1-induced prostaglandin reductase 1 expression and reduction of phagocytosisBiochimica et biophysica acta. Molecular cell researchApril 1, 2017Kang GJ, Lee HJ, Byun HJ, Kim EJ, Kim HJ, Park MK, Lee CH.

(16) GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagyAutophagyJanuary 2, 2017Kim M, Jung JY, Choi S, Lee H, Morales LD, Koh JT, Kim SH, Choi YD, Choi C, Slaga TJ, et al.

(17) HMGB1 induces human non-small cell lung cancer cell motility by activating integrin αvβ3/FAK through TLR4/NF-κB signaling pathwayBiochemical and biophysical research communicationsNovember 25, 2016Zhu J, Luo J, Li Y, Jia M, Wang Y, Huang Y, Ke S.

(18) Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance RegulatorMolecular therapy : the journal of the American Society of Gene TherapyAugust 1, 2016Saayman SM, Ackley A, Burdach J, Clemson M, Gruenert DC, Tachikawa K, Chivukula P, Weinberg MS, Morris KV.HMGA1 (siRNA sc-44333, Santa Cruz, Santa Cruz, CA), HMGN2 (siRNA sc-37988, Santa Cruz), HMGB1 (siRNA sc-37982, Santa Cruz), WIBG (siRNA sc-96076, Santa Cruz) and a scrambled control (siRNA sc- 37007, Santa Cruz)

(19) Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancerInternational journal of cancerOctober 1, 2015Chung HW, Jang S, Kim H, Lim JB.

(20) Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivoBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicasJune 1, 2015Zhang L, Ji YX, Jiang WL, Lv CJ.

Be the First to Write a Review!

HMG-1 siRNA (h)

HMG-1 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (26)

Reviews

HMG-1 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map